EMBRACE Study: Enduring Migraine Benefit From Responsive Artery Coil Embolization (NCT07313800)
Enduring Migraine Benefit From Responsive Artery Coil Embolization (EMBRACE): A Single-Site, Non-Significant Risk Pilot Study of Middle Meningeal Artery Embolization Using FDA-Cleared Coils for Refractory Episodic Migraine
🩺 Plain-English Summary (8th-Grade Level)
This single-site, open-label pilot study evaluates the safety, feasibility, and potential durability of the TEMMA procedure (Targeted Embolization for Migraine Management), an endovascular treatment strategy targeting meningeal arterial contributors to migraine. Adults aged 18-60 with refractory migraine despite prior preventive therapies are eligible. The study assesses migraine outcomes over 12 months using patient-reported headache frequency, pain intensity, acute medication use, migraine-related disability (MIDAS), and quality-of-life measures (MSQ v2.1).
Who can join: Review the eligibility criteria below.
Location: Cortex Neurovascular / TRA Union — Tacoma, Washington
Age range: 18 Years to 60 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Cortex Neurovascular / TRA Union — Tacoma, Washington
📞 Contact the Study Coordinator
Phone: (253) 761-4200
Email: dwang@cortexmgmt.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Migraine Disorders
- Using Virtual Reality to Teach Mindfulness to People With Migraine — Boston, Massachusetts
- EMBRACE-OBS: Single-Site Observational Registry of Patient-Reported Outcomes Following MMA Embolization for Migraine — Tacoma, Washington
- MMA Embolization for Refractory Chronic Migraine — Walnut Creek, California
- Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old — Birmingham, Alabama
Explore by condition: All Migraine Disorders clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.